Pramiracetam

Pramiracetam is a nootropic drug derived from piracetam, and is more potent (i.e., lower dosage is used). It belongs to the racetam family of nootropics. Pramiracetam was developed by Parke-Davis based on Piracetam, and is 8-30 times stronger than Piracetam. It goes by the trade name Neupramir, Pramistar, and Remen (Parke-Davis), and is marketed in Europe by Menarini.

Pharmacology[edit | edit source]

Pramiracetam is believed to increase acetylcholine utilization in the hippocampus. Acetylcholine is a neurotransmitter that is critical for the formation of new memories. Pramiracetam's mechanism of action is not fully understood, but it is known to increase blood flow and activity in the brain, particularly in the area of memory processing.

Medical uses[edit | edit source]

Pramiracetam is used in the treatment of memory and attention deficits in aging people with neurodegenerative and vascular dementias in Italy and some other European countries.

Side effects[edit | edit source]

Common side effects include increased blood pressure and heart rate, trouble sleeping, and nausea. More serious side effects may include hallucinations, severe rash, and anemia.

References[edit | edit source]

Pramiracetam Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.